Physical function improvements and relief from fatigue and pain are associated with increased productivity at work and at home in rheumatoid arthritis patients treated with certolizumab pegol.
OBJECTIVES: To evaluate the association between improvements in physical function, fatigue and pain and improvements in productivity at work and at home in patients treated with certolizumab pegol (CZP) in combination with MTX. METHODS: Physical function, fatigue and pain were assessed in two CZP c...
Egile Nagusiak: | Hazes, J, Taylor, P, Strand, V, Purcaru, O, Coteur, G, Mease, P |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
2010
|
Antzeko izenburuak
-
Certolizumab pegol in therapy for rheumatoid arthritis
nork: Galina Viktorovna Lukina, et al.
Argitaratua: (2012-06-01) -
COST-EFFECTIVENESS OF CERTOLIZUMAB PEGOL PLUS METHOTREXATE OR AS MONOTHERAPY FOR THE TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS IN THE UNITED KINGDOM
nork: Purcaru, O, et al.
Argitaratua: (2010) -
QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH CERTOLIZUMAB PEGOL
nork: Vera Nikolayevna Amirdjanova, et al.
Argitaratua: (2012-10-01) -
Certolizumab pegol (CIMZIA®) for the treatment of rheumatoid arthritis
nork: M Connock, et al.
Argitaratua: (2010-10-01) -
Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
nork: Ruiz Garcia, V, et al.
Argitaratua: (2014)